Stryker completed its Entellus Medical acquisition, according to Zenopa.
Here are four highlights:
1. As predicted, Stryker acquired the ENT company for $662 million.
2. Entellus Medical focuses on providing minimally invasive solutions for various ear, nose and throat conditions.
3. Entellus Medical has a range of products, including the XprESS multi-sinus dilation system and Latera absorbable nasal implant.
4. The acquisition is anticipated to dilute Stryker's 2018 adjusted net earnings by $0.04 per share.